These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 12579316

  • 1. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK, Buckley PG, Benetkiewicz M, De Bustos C, Hirvelä C, Jarbo C, Bruder CE, Wensman H, Mathiesen T, Nyberg G, Papi L, Collins VP, Ichimura K, Evans G, Dumanski JP.
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [Abstract] [Full Text] [Related]

  • 2. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
    Benetkiewicz M, Wang Y, Schaner M, Wang P, Mantripragada KK, Buckley PG, Kristensen G, Børresen-Dale AL, Dumanski JP.
    Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
    [Abstract] [Full Text] [Related]

  • 3. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE, Ichimura K, Blennow E, Ikeuchi T, Yamaguchi T, Yuasa Y, Collins VP, Dumanski JP.
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [Abstract] [Full Text] [Related]

  • 4. High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.
    Díaz de Ståhl T, Hansson CM, de Bustos C, Mantripragada KK, Piotrowski A, Benetkiewicz M, Jarbo C, Wiklund L, Mathiesen T, Nyberg G, Collins VP, Evans DG, Ichimura K, Dumanski JP.
    Hum Genet; 2005 Oct; 118(1):35-44. PubMed ID: 16078050
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
    Bian LG, Sun QF, Tirakotai W, Zhao WG, Shen JK, Luo QZ, Bertalanffy H.
    Chin Med J (Engl); 2005 Sep 20; 118(18):1517-24. PubMed ID: 16232328
    [Abstract] [Full Text] [Related]

  • 6. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
    Kambe A, Kamitani H, Watanabe T, Oka A, Inagaki H, Ishii T, Ueki K.
    Surg Neurol; 2005 Jan 20; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM, Buckley PG, Grigelioniene G, Piotrowski A, Hellström AR, Mantripragada K, Jarbo C, Mathiesen T, Dumanski JP.
    BMC Genomics; 2007 Jan 12; 8():16. PubMed ID: 17222329
    [Abstract] [Full Text] [Related]

  • 8. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
    Buckley PG, Mantripragada KK, Díaz de Ståhl T, Piotrowski A, Hansson CM, Kiss H, Vetrie D, Ernberg IT, Nordenskjöld M, Bolund L, Sainio M, Rouleau GA, Niimura M, Wallace AJ, Evans DG, Grigelionis G, Menzel U, Dumanski JP.
    Hum Mutat; 2005 Dec 12; 26(6):540-9. PubMed ID: 16287142
    [Abstract] [Full Text] [Related]

  • 9. Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.
    Martínez-Glez V, Alvarez L, Franco-Hernández C, Torres-Martin M, de Campos JM, Isla A, Vaquero J, Lassaletta L, Castresana JS, Casartelli C, Rey JA.
    Cancer Genet Cytogenet; 2010 Jan 01; 196(1):1-6. PubMed ID: 19963129
    [Abstract] [Full Text] [Related]

  • 10. Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity.
    Benetkiewicz M, Piotrowski A, Díaz De Ståhl T, Jankowski M, Bala D, Hoffman J, Srutek E, Laskowski R, Zegarski W, Dumanski JP.
    Int J Oncol; 2006 Oct 01; 29(4):935-45. PubMed ID: 16964389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG, Jarbo C, Menzel U, Mathiesen T, Scott C, Gregory SG, Langford CF, Dumanski JP.
    Cancer Res; 2005 Apr 01; 65(7):2653-61. PubMed ID: 15805262
    [Abstract] [Full Text] [Related]

  • 13. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.
    Cancer Res; 1999 Dec 01; 59(23):5995-8. PubMed ID: 10606247
    [Abstract] [Full Text] [Related]

  • 14. Molecular characterization of chromosome 22 deletions in schwannomas.
    Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJ.
    Genes Chromosomes Cancer; 1992 Oct 01; 5(3):201-5. PubMed ID: 1384671
    [Abstract] [Full Text] [Related]

  • 15. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG.
    Oncogene; 2010 Nov 25; 29(47):6216-21. PubMed ID: 20729918
    [Abstract] [Full Text] [Related]

  • 16. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE, Ichimura K, Tingby O, Hirakawa K, Komatsuzaki A, Tamura A, Yuasa Y, Collins VP, Dumanski JP.
    Hum Genet; 1999 May 25; 104(5):418-24. PubMed ID: 10394935
    [Abstract] [Full Text] [Related]

  • 17. DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets.
    Mantripragada KK, Tapia-Páez I, Blennow E, Nilsson P, Wedell A, Dumanski JP.
    Int J Mol Med; 2004 Feb 25; 13(2):273-9. PubMed ID: 14719134
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
    Koolen DA, Reardon W, Rosser EM, Lacombe D, Hurst JA, Law CJ, Bongers EM, van Ravenswaaij-Arts CM, Leisink MA, van Kessel AG, Veltman JA, de Vries BB.
    Eur J Hum Genet; 2005 Sep 25; 13(9):1019-24. PubMed ID: 15986041
    [Abstract] [Full Text] [Related]

  • 19. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE, Bello MJ, de Campos JM, Vaquero J, Sarasa JL, Pestaña A, Rey JA.
    Oncogene; 1999 Apr 01; 18(13):2231-9. PubMed ID: 10327069
    [Abstract] [Full Text] [Related]

  • 20. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
    Nunes F, Shen Y, Niida Y, Beauchamp R, Stemmer-Rachamimov AO, Ramesh V, Gusella J, MacCollin M.
    Cancer Genet Cytogenet; 2005 Oct 15; 162(2):135-9. PubMed ID: 16213361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.